Tet2 is one of the most frequently mutated genes in hematological cancers (7–9), such as angioimmunoblastic T cell lymphoma (AITL) (10–12) and peripheral T cell lymphoma, non-otherwise specified (PTCL-NOS) (13). This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.